Nintedanib (BIBF1120), a triple angiokinase inhibitor, was first approved for idiopathic pulmonary fibrosis (IPF) therapy and also efficacious for lung carcinoma, interstitial lung diseases, far beyond its inhibition of VEGFR/PDGFR/FGFR....
We described a chemoproteomics approach to identify TBK1 as a key target of the multikinase inhibitor nintedanib in IPF. This insight may facilitate a better understanding of the functional mechanism of nintedanib for antifibrosis efficacy.
Celastrol
(CEL), a pentacyclic triterpene compound, has been proven
to have a definite antipulmonary fibrosis effect. However, its direct
targets for antipulmonary fibrosis remain unknown. In this study,
we designed and synthesized a series of celastrol-based probes to
identify the direct targets in human pulmonary fibroblasts using an
activity-based protein profiling strategy. Among many fished targets,
we identified a key protein, cullin-associated and neddylation-dissociated
1 (CAND1), which was involved in fibroblast–myofibroblast transformation
(FMT). More importantly, we found that the inhibitory effect of celastrol
on FMT is dependent on CAND1, through improving the interactions between
CAND1 and Cullin1 to promote the activity of Skp1/Cullin1/F-box ubiquitin
ligases. In silico studies and cysteine mutation experiments further
demonstrated that Cys264 of CAND1 is the site for conjugation of celastrol.
This reveals a new mechanism of celastrol against pulmonary fibrosis
and may provide a novel therapeutic option for antipulmonary fibrosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.